Christobel Selecky, Director at ImmunityBio, Inc. (IBRX), sold 96,722 shares at $9.01 ($871K) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($871k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.01 | 95,722 | $862K | 99.0% |
| 2 | $9.00 | 1,000 | $9K | 1.0% |
| Total | $9.01 avg | 96,722 | $871K | 100% |
| Filing → |
| IBRX | SELL | 2026-01-21 | $625K | — | Filing → |